We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$618B
AUM Growth
-$47.4B
Cap. Flow
-$19.5B
Cap. Flow %
-3.16%
Top 10 Hldgs %
21.78%
Holding
14,860
New
2,347
Increased
5,138
Reduced
5,286
Closed
2,003

Sector Composition

Rank Sector Weight
1 Technology 4.49%
2 Healthcare 2.99%
3 Financials 2.85%
4 Industrials 2.56%
5 Consumer Discretionary 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNCY icon
9051
PUT
Unicycive Therapeutics
UNCY
$130M
$543K ﹤0.01%
+82,500
New +$541K
CNK icon
9052
PUT
Cinemark Holdings
CNK
$4.07B
$542K ﹤0.01%
19,000
-22,600
-54% -$579K
BHAVU
9053
BHAV Acquisition Corp Units
BHAVU
$542K ﹤0.01%
+54,348
New +$542K
PINE
9054
CALL
Alpine Income Property Trust
PINE
$336M
$542K ﹤0.01%
30,100
+3,600
+14% +$66.9K
BCRX icon
9055
CALL
BioCryst Pharmaceuticals
BCRX
$2.42B
$542K ﹤0.01%
56,885
-24,715
-30% -$192K
MAMA icon
9056
CALL
Mama's Creations
MAMA
$846M
$542K ﹤0.01%
35,300
+8,900
+34% +$135K
MRAM icon
9057
CALL
Everspin Technologies
MRAM
$303M
$541K ﹤0.01%
61,600
+9,800
+19% +$108K
GLUE icon
9058
PUT
Monte Rosa Therapeutics
GLUE
$1.82B
$541K ﹤0.01%
32,900
+13,400
+69% +$256K
ARCB icon
9059
PUT
ArcBest
ARCB
$3.15B
$541K ﹤0.01%
5,500
-26,400
-83% -$2.5M
IFGL icon
9060
iShares International Developed Real Estate ETF
IFGL
$82.8M
$541K ﹤0.01%
24,194
+11,963
+98% +$286K
DBO icon
9061
PUT
Invesco DB Oil Fund
DBO
$401M
$541K ﹤0.01%
27,500
+12,500
+83% +$193K
ETD icon
9062
CALL
Ethan Allen Interiors
ETD
$600M
$541K ﹤0.01%
24,300
-12,500
-34% -$290K
SMDV icon
9063
ProShares Russell 2000 Dividend Growers ETF
SMDV
$701M
$541K ﹤0.01%
7,863
-5,280
-40% -$371K
SCSC icon
9064
PUT
Scansource
SCSC
$1.17B
$541K ﹤0.01%
14,900
+3,300
+28% +$126K
PSFM icon
9065
Pacer Swan SOS Flex April ETF
PSFM
$25.2M
$540K ﹤0.01%
+16,661
New +$534K
MVIS icon
9066
Microvision
MVIS
$84.8M
$540K ﹤0.01%
+842,333
New +$643K
MOV icon
9067
CALL
Movado Group
MOV
$840M
$540K ﹤0.01%
+22,100
New +$523K
ORKA
9068
CALL
Oruka Therapeutics
ORKA
$5.31B
$540K ﹤0.01%
+11,000
New +$382K
MLPB icon
9069
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
$248M
$539K ﹤0.01%
18,583
+248
+1% +$6.88K
HOVR icon
9070
New Horizon Aircraft
HOVR
$106M
$539K ﹤0.01%
+382,391
New +$728K
RGC icon
9071
CALL
Regencell Bioscience
RGC
$2.79B
$539K ﹤0.01%
+21,200
New +$600K
TRTX
9072
CALL
TPG RE Finance Trust
TRTX
$635M
$539K ﹤0.01%
69,000
-2,351,800
-97% -$20.3M
FNGO icon
9073
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$595M
$539K ﹤0.01%
+6,174
New +$629K
HR icon
9074
CALL
Healthcare Realty
HR
$7.56B
$539K ﹤0.01%
31,700
-28,700
-48% -$503K
KBE icon
9075
State Street SPDR S&P Bank ETF
KBE
$1.64B
$538K ﹤0.01%
9,040
-189,678
-95% -$11.8M

Similar funds

Citadel Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Citadel Advisors withdrew a net $19.5B in Q1 2026, closing 2,003 positions and reducing 5,286 holdings. Its most notable exit was CyberArk, an estimated $305M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares 7-10 Year Treasury Bond ETF worth $327M.

  • Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
  • Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
  • Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
  • Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
  • Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
  • Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.